GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 166   

Articles published

GSK 47.84 +0.12 (0.25%)
price chart
GlaxoSmithKline plc (ADR) To Close Asset Swap Deal With Novartis AG (ADR ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced on Wednesday that it anticipates closing the mega-billion dollar asset exchange with Novartis AG (ADR) (NYSE:NVS) in the week beginning March 2, 2015.
Novartis AG (ADR), GlaxoSmithKline plc (ADR) Recieve Final Approval For Thee ...
According to the US Federal Trade Commission's (FTC) announcement yesterday, Novartis (NYSE:NVS) has received the US antitrust regulator's approval to acquire drugs from Glaxo's oncology portfolio, contingent upon certain specified conditions.
Company Shares of GlaxoSmithKline plc (ADR) Drops by -1.23%
GlaxoSmithKline plc (ADR) (NYSE:GSK) has dropped 1.23% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 5.2% in the last 4 weeks.
Zacks Rating Update on GlaxoSmithKline plc (ADR)  Stafford Daily
GlaxoSmithKline plc (ADR) (NYSE:GSK) Update: GlaxoSmithKline weakness ...  Rock Hill Daily
Analyst Rating Update on GlaxoSmithKline plc (ADR)
As many as 7 brokerage firms have rated Glaxosmithkline Plc (NYSE:GSK) at 2.57. Research Analysts at Zacks have ranked the company at 3, suggesting the traders with a rating of hold for the short term.
GlaxoSmithKline plc (ADR) ViiV Spinoff
Despite reporting troubled earnings and revenues Wednesday, GlaxoSmithKline plc ADR (NYSE:GSK) has been on an uptrend, after announcing various growth plans to stabilize the business.
Earnings Update on GlaxoSmithKline plc (ADR)  Bar and Graph Report
GlaxoSmithKline plc (ADR) Announces $0.70 Quarterly Dividend (GSK)  Mideast Time
GlaxoSmithKline plc (ADR) (GSK) In The Green After UBS Upgrades Stock To ...
Shares of GlaxoSmithKline Plc (ADR) (NYSE:GSK)�the world's leading research-based pharmaceutical company�are in the green today after UBS, the Swiss global financial services company, upgraded it from a �Sell� to a �Buy.
Large Inflow of Money Witnessed in GlaxoSmithKline plc (ADR)  Stafford Daily
Mid Cap Stock's Buzzers - GlaxoSmithKline (GSK), Suncor Energy (SU ...  Techsonian (press release)
GlaxoSmithKline plc (ADR) Analyst Rating Update
Analysts at Zacks have given a Underperform rating on GlaxoSmithKline plc (ADR) (NYSE:GSK) with a rank of 5. The counter has received an average rating of 2.57 from 7 brokerage firms.
GlaxoSmithKline plc (ADR) Acquires Vaccine Maker GlycoVaxyn For $190 Million
GlaxoSmithKline Plc (ADR) (NYSE:GSK) announced Wednesday morning that it is acquiring the specialist Swiss vaccine maker, GlycoVaxyn, in a $190 million deal.
GlaxoSmithKline plc (ADR) Receives Average Target Price of $51.54
GlaxoSmithKline plc (ADR) (NYSE:GSK): 2 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $51.54 in GlaxoSmithKline plc (ADR) (NYSE:GSK). However, the stock price could fluctuate by $ 10.55 from the estimate ...
Glaxosmithkline Plc (ADR) (NYSE:GSK)'s Roadmap For HIV Drugs Business  InvestCorrectly
Brokerage Firm Rating Disclosure Update on GlaxoSmithKline plc (ADR)
A number of Equity Analysts have issued recommendation on the company shares and the short term and long term price targets. GlaxoSmithKline plc (ADR) (NYSE:GSK) is a hold, according to the latest average broker rating of 3.14. The number of analysts ...
The Street Rating Update on GlaxoSmithKline plc (ADR)  Wall Street Pulse
Company Shares of GlaxoSmithKline plc (ADR) Rally 4.55%  Ashburn Daily